These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
234 related items for PubMed ID: 10835873
21. Hypertension in patients with diabetes mellitus: prevalence, aetiology and consequences. de Nobel E, Elving LD, Bilo HJ, Gans RO. Neth J Med; 1989 Dec; 35(5-6):267-75. PubMed ID: 2699652 [No Abstract] [Full Text] [Related]
22. [Risk factors of diabetic nephropathy progression in patients with a long history of diabetic mellitus as shown by a retrospective analysis]. Shestakova MV, Koshel' LV, Vagodin VA, Dedov II. Ter Arkh; 2006 Dec; 78(5):60-4. PubMed ID: 16889052 [Abstract] [Full Text] [Related]
23. Hereditary factors in the development of diabetic renal disease. Marre M, Hadjadj S, Bouhanick B. Diabetes Metab; 2000 Jul; 26 Suppl 4():30-6. PubMed ID: 10922971 [Abstract] [Full Text] [Related]
26. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance? Vogt L, Kocks MJ, Laverman GD, Navis G. Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515 [Abstract] [Full Text] [Related]
30. [Has the incidence of end-stage renal disease increased in diabetic patients? A center-based longitudinal study over 10 years]. Van Landeghem MA. Med Klin (Munich); 2005 May 13; 100(5):241-5. PubMed ID: 15902377 [Abstract] [Full Text] [Related]
34. [Diabetic nephropathy]. Morcos M, Zeier M, Schwenger V. Dtsch Med Wochenschr; 2007 May 11; 132(19):1039-42. PubMed ID: 17476634 [No Abstract] [Full Text] [Related]
35. Heat-shock protein gene polymorphisms and the risk of nephropathy in patients with Type 2 diabetes. Buraczynska M, Swatowski A, Buraczynska K, Dragan M, Ksiazek A. Clin Sci (Lond); 2009 Jan 11; 116(1):81-6. PubMed ID: 18518860 [Abstract] [Full Text] [Related]
36. Adequate protein dietary restriction in diabetic and nondiabetic patients with chronic renal failure. Meloni C, Tatangelo P, Cipriani S, Rossi V, Suraci C, Tozzo C, Rossini B, Cecilia A, Di Franco D, Straccialano E, Casciani CU. J Ren Nutr; 2004 Oct 11; 14(4):208-13. PubMed ID: 15483780 [Abstract] [Full Text] [Related]
37. [Strategies to reduce the progression of renal disease in patients with type II diabetes mellitus]. Burgos Calderón R. P R Health Sci J; 2001 Jun 11; 20(2):157-60. PubMed ID: 11561475 [Abstract] [Full Text] [Related]
38. The economic benefits of preventing end-stage renal disease in patients with type 2 diabetes mellitus. Postma MJ, de Zeeuw D. Nephrol Dial Transplant; 2009 Oct 11; 24(10):2975-83. PubMed ID: 19605601 [No Abstract] [Full Text] [Related]
39. Treatment of end-stage renal failure due to diabetes in the United Kingdom. Cameron JS. J Diabetes Complications; 1992 Oct 11; 6(1):1-6. PubMed ID: 1562752 [No Abstract] [Full Text] [Related]
40. Current concepts of diabetes mellitus. Aschner P. Int Ophthalmol Clin; 1998 Oct 11; 38(2):1-10. PubMed ID: 9604734 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]